Evopoint Biosciences Co., Ltd.

¥39.50As of Sun 8 Nov 2026, 12:00 UTC
SSE:688837Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap ¥17.20B
ROIC (55.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥41
3.03%
121.91%
Hold 2|9|3|7|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.38
0.41
0.43
0.44
(0.60%)
8.51%
12.01%
18.76%
Revenue¥B
1.170
1.164
1.164
1.205
8.84%
10.79%
9.76%
8.34%
Peers (US$2.579B)
Cap (US$)
PE
2.722B
—
2.700B
36.65x
Capital
TTM
5Y
10Y
Leveragex
1.616
(0.696)
(0.643)
EBIT/Intx
2.691
0.316
0.302
Own earn%
(84.91)
(4.62)
(4.55)
Sh yield%
43.64
5.16
9.49
Owners
Insiders/Inst%
14.34
48.46
Short interest%
4.19
SBC / revenue%
5.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–4
$1 testx
3.1
Incr. ROIC%
7